RCUS logo

Arcus Biosciences, Inc. (RCUS) EBITDA

Annual EBITDA:

-$269.00M+$22.00M(+7.56%)
December 31, 2024

Summary

  • As of today, RCUS annual EBITDA is -$269.00 million, with the most recent change of +$22.00 million (+7.56%) on December 31, 2024.
  • During the last 3 years, RCUS annual EBITDA has fallen by -$328.00 million (-555.93%).
  • RCUS annual EBITDA is now -555.93% below its all-time high of $59.00 million, reached on December 31, 2021.

Performance

RCUS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUSincome statement metrics

Quarterly EBITDA:

-$140.00M-$134.00M(-2233.33%)
September 30, 2025

Summary

  • As of today, RCUS quarterly EBITDA is -$140.00 million, with the most recent change of -$134.00 million (-2233.33%) on September 30, 2025.
  • Over the past year, RCUS quarterly EBITDA has dropped by -$37.00 million (-35.92%).
  • RCUS quarterly EBITDA is now -149.34% below its all-time high of $283.74 million, reached on December 31, 2021.

Performance

RCUS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUSincome statement metrics

TTM EBITDA:

-$365.00M-$37.00M(-11.28%)
September 30, 2025

Summary

  • As of today, RCUS TTM EBITDA is -$365.00 million, with the most recent change of -$37.00 million (-11.28%) on September 30, 2025.
  • Over the past year, RCUS TTM EBITDA has dropped by -$79.00 million (-27.62%).
  • RCUS TTM EBITDA is now -511.26% below its all-time high of $88.75 million, reached on September 30, 2022.

Performance

RCUS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRCUSincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

RCUS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+7.6%-35.9%-27.6%
3Y3 Years-555.9%-112.8%-511.3%
5Y5 Years-231.6%-4224.9%-327.3%

RCUS EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-555.9%+7.6%-2100.0%at low-511.3%+14.3%
5Y5-Year-555.9%+7.6%-149.3%at low-511.3%+14.3%
All-TimeAll-Time-555.9%+7.6%-149.3%at low-511.3%+14.3%

RCUS EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$140.00M(-2233.3%)
-$365.00M(-11.3%)
Jun 2025
-
-$6.00M(+95.0%)
-$328.00M(+23.0%)
Mar 2025
-
-$119.00M(-19.0%)
-$426.00M(-42.0%)
Dec 2024
-$269.00M(+7.6%)
-$100.00M(+2.9%)
-$300.00M(-4.9%)
Sep 2024
-
-$103.00M(+1.0%)
-$286.00M(-10.0%)
Jun 2024
-
-$104.00M(-1585.7%)
-$260.00M(-10.6%)
Mar 2024
-
$7.00M(+108.1%)
-$235.00M(+27.5%)
Dec 2023
-$291.00M(-12.8%)
-$86.00M(-11.7%)
-$324.00M(-4.9%)
Sep 2023
-
-$77.00M(+2.5%)
-$309.01M(-3.8%)
Jun 2023
-
-$79.00M(+3.7%)
-$297.80M(-4.8%)
Mar 2023
-
-$82.00M(-15.5%)
-$284.25M(-6.9%)
Dec 2022
-$258.00M(-537.3%)
-$71.01M(-7.9%)
-$266.00M(-399.7%)
Sep 2022
-
-$65.79M(-0.5%)
$88.75M(+13.7%)
Jun 2022
-
-$65.45M(-2.7%)
$78.05M(+13.3%)
Mar 2022
-
-$63.75M(-122.5%)
$68.87M(+13.3%)
Dec 2021
$59.00M
$283.74M(+471.0%)
$60.77M(+122.2%)
Sep 2021
-
-$76.49M(-2.5%)
-$273.17M(-41.3%)
Jun 2021
-
-$74.64M(-3.9%)
-$193.28M(-18.4%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$71.85M(-43.1%)
-$163.23M(-37.2%)
Dec 2020
-$120.00M(-47.9%)
-$50.19M(-1578.8%)
-$118.94M(-39.2%)
Sep 2020
-
$3.39M(+107.6%)
-$85.42M(+23.2%)
Jun 2020
-
-$44.59M(-61.8%)
-$111.27M(-17.1%)
Mar 2020
-
-$27.56M(-65.3%)
-$95.04M(-11.4%)
Dec 2019
-$81.13M(-58.5%)
-$16.67M(+25.7%)
-$85.30M(-5.1%)
Sep 2019
-
-$22.45M(+20.8%)
-$81.17M(-16.0%)
Jun 2019
-
-$28.36M(-59.1%)
-$69.96M(-23.6%)
Mar 2019
-
-$17.82M(-42.1%)
-$56.59M(-10.4%)
Dec 2018
-$51.20M(-0.7%)
-$12.54M(-11.5%)
-$51.27M(+0.1%)
Sep 2018
-
-$11.24M(+25.0%)
-$51.31M(+17.9%)
Jun 2018
-
-$14.98M(-19.8%)
-$62.50M(-10.5%)
Mar 2018
-
-$12.50M(+0.6%)
-$56.55M(-11.2%)
Dec 2017
-$50.83M(-201.3%)
-$12.58M(+43.9%)
-$50.86M(-32.9%)
Sep 2017
-
-$22.43M(-148.3%)
-$38.28M(-141.5%)
Jun 2017
-
-$9.04M(-32.6%)
-$15.85M(-132.6%)
Mar 2017
-
-$6.81M
-$6.81M
Dec 2016
-$16.87M
-
-

FAQ

  • What is Arcus Biosciences, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. annual EBITDA year-on-year change?
  • What is Arcus Biosciences, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. quarterly EBITDA year-on-year change?
  • What is Arcus Biosciences, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Arcus Biosciences, Inc.?
  • What is Arcus Biosciences, Inc. TTM EBITDA year-on-year change?

What is Arcus Biosciences, Inc. annual EBITDA?

The current annual EBITDA of RCUS is -$269.00M

What is the all-time high annual EBITDA for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high annual EBITDA is $59.00M

What is Arcus Biosciences, Inc. annual EBITDA year-on-year change?

Over the past year, RCUS annual EBITDA has changed by +$22.00M (+7.56%)

What is Arcus Biosciences, Inc. quarterly EBITDA?

The current quarterly EBITDA of RCUS is -$140.00M

What is the all-time high quarterly EBITDA for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high quarterly EBITDA is $283.74M

What is Arcus Biosciences, Inc. quarterly EBITDA year-on-year change?

Over the past year, RCUS quarterly EBITDA has changed by -$37.00M (-35.92%)

What is Arcus Biosciences, Inc. TTM EBITDA?

The current TTM EBITDA of RCUS is -$365.00M

What is the all-time high TTM EBITDA for Arcus Biosciences, Inc.?

Arcus Biosciences, Inc. all-time high TTM EBITDA is $88.75M

What is Arcus Biosciences, Inc. TTM EBITDA year-on-year change?

Over the past year, RCUS TTM EBITDA has changed by -$79.00M (-27.62%)
On this page